Should you build or buy Electronic Prescribing (eRx)?
Electronic prescribing software transmits prescriptions from a clinician's system directly to a pharmacy over the Surescripts network, using the NCPDP SCRIPT standard, with drug interaction checking, formulary lookup and, for controlled substances, DEA-certified identity verification. Health systems and EHR vendors license it rather than connecting to the network directly.
License a certified eRx service (DrFirst, DoseSpot, MDToolbox or an EHR-embedded module) and spend engineering on your own clinical workflow and integration; a direct Surescripts build only makes sense if e-prescribing is itself the product you sell.
Build it, buy it, or bridge?
When building makes sense
There is essentially no build case for a provider organization here, and understanding why is more useful than pretending otherwise. Building direct means implementing the NCPDP SCRIPT standard, version 2017071 or 2023011, with the older version retiring December 31, 2027, plus completing Surescripts network certification and passing a third-party EPCS audit that recurs at least every two years, with identity-proofing for every prescriber. AI coding tools can help write the NCPDP SCRIPT message handling itself, but that code is the easy part of this project. Independent software vendors like DAW Systems and RXNT have done this work and hold Surescripts Gold certification, but they did it to sell the resulting product, not to use it internally. No hospital, clinic or health system is documented running a self-built certified eRx stack for its own use. The certification burden and recurring audit cost only make sense to absorb if e-prescribing infrastructure is the product you sell to other providers.
When buying makes sense
License a certified eRx service and put your engineering effort into the clinical workflow and EHR integration around it. DrFirst Rcopia runs about $400 to $475 a year per prescriber, DoseSpot's own pricing page cites $500 to $799 a year per prescriber, plus an implementation fee that runs from a few thousand dollars to more than $10,000, and MDToolbox prices in the $28 to $35 per month per prescriber range. All three are cheaper than the certification and recurring audit burden a self-built connection would require. EPCS for controlled substances adds its own layer: the average yearly cost per prescriber for EPCS falls between $75 and $135, plus a DEA-required third-party audit roughly every two years that runs about $2,000 regardless of vendor. Buy a certified module and spend your integration budget on making the prescribing workflow fit your clinicians' actual process; the Surescripts connection itself is solved infrastructure you rent.
The desk read
Build-versus-buy analysis for Electronic Prescribing (eRx) is being written. In the meantime, the framework that drives every B4 call is on the B4 Index page.
Frequently asked
What is electronic prescribing (eRx) software?
It is the certified bridge between a clinician's system and a pharmacy. DAW Systems and RXNT are examples of vendors that built and hold Surescripts Gold certification specifically to sell that bridge to health systems, rather than each health system certifying its own connection.
Why don't health systems build their own e-prescribing connection?
Because it requires NCPDP SCRIPT implementation, Surescripts network certification, and a recurring third-party EPCS audit every two years, with no competitive benefit since every prescriber uses the same network regardless of who built the connection.
What does e-prescribing software cost?
Licensed modules run roughly $500 to $1,200 a month for ten-plus prescribers. DoseSpot cites $500 to $799 a year per prescriber plus an implementation fee from a few thousand dollars to more than $10,000; EPCS for controlled substances adds $75 to $135 a year per prescriber plus a periodic DEA audit.
What are the main eRx vendors?
Representative vendors include DoseSpot, DrFirst Rcopia. B4 Pro includes the category score and the full vendor list.